These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 36873354)

  • 1. Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors.
    Yin X; He Z; Ge W; Zhao Z
    Front Bioeng Biotechnol; 2023; 11():1092901. PubMed ID: 36873354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Aptamer-Embedded Nanomaterials for Diagnostics and Therapeutics.
    Xie S; Ai L; Cui C; Fu T; Cheng X; Qu F; Tan W
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):9542-9560. PubMed ID: 33595277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of dual-functional composite magnetic nanomaterials modified with different metals/aptamers and their performance in exosome enrichment].
    Zhang W; Lu R; Zhang L
    Se Pu; 2021 Oct; 39(10):1128-1136. PubMed ID: 34505435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Aptamer-Bound Nanomaterials in Cancer Therapy.
    Zhu L; Zhao J; Guo Z; Liu Y; Chen H; Chen Z; He N
    Biosensors (Basel); 2021 Sep; 11(9):. PubMed ID: 34562934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging.
    Liu M; Wang L; Lo Y; Shiu SC; Kinghorn AB; Tanner JA
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy.
    Liu Q; Jin C; Wang Y; Fang X; Zhang X; Chen Z; Tan W
    NPG Asia Mater; 2014; 6():. PubMed ID: 29619132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
    Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
    Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics.
    Gholikhani T; Kumar S; Valizadeh H; Mahdinloo S; Adibkia K; Zakeri-Milani P; Barzegar-Jalali M; Jimenez B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
    Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
    Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in aptamer-mediated targeted delivery system for cancer treatment.
    He S; Du Y; Tao H; Duan H
    Int J Biol Macromol; 2023 May; 238():124173. PubMed ID: 36965552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges.
    He F; Wen N; Xiao D; Yan J; Xiong H; Cai S; Liu Z; Liu Y
    Curr Med Chem; 2020; 27(13):2189-2219. PubMed ID: 30295183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleotide aptamers: new tools for targeted cancer therapy.
    Sun H; Zhu X; Lu PY; Rosato RR; Tan W; Zu Y
    Mol Ther Nucleic Acids; 2014 Aug; 3(8):e182. PubMed ID: 25093706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells
    Xing H; Tang L; Yang X; Hwang K; Wang W; Yin Q; Wong NY; Dobrucki LW; Yasui N; Katzenellenbogen JA; Helferich WG; Cheng J; Lu Y
    J Mater Chem B; 2013 Oct; 1(39):5288-5297. PubMed ID: 24159374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamers used for biosensors and targeted therapy.
    Ning Y; Hu J; Lu F
    Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology.
    Chen C; Zhou S; Cai Y; Tang F
    NPJ Precis Oncol; 2017; 1(1):37. PubMed ID: 29872716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progresses in biomedical applications of aptamer-functionalized systems.
    Ding F; Gao Y; He X
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4256-4269. PubMed ID: 28803753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages of Material Biofunctionalization Using Nucleic Acid Aptamers in Tissue Engineering and Regenerative Medicine.
    Abpeikar Z; Alizadeh AA; Rezakhani L; Ramezani V; Goodarzi A; Safaei M
    Mol Biotechnol; 2023 Dec; 65(12):1935-1953. PubMed ID: 37017917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-Mediated Targeted Delivery of Therapeutics: An Update.
    Catuogno S; Esposito CL; de Franciscis V
    Pharmaceuticals (Basel); 2016 Nov; 9(4):. PubMed ID: 27827876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-Functionalized Hybrid Nanostructures for Sensing, Drug Delivery, Catalysis and Mechanical Applications.
    Vázquez-González M; Willner I
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer based recognition of cancer cells: Recent progress and challenges in bioanalysis.
    Kordasht HK; Hasanzadeh M
    Talanta; 2020 Dec; 220():121436. PubMed ID: 32928438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.